The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to procure reagents from 10X Genomics, Inc. for the Critical Care Medicine Department (CCMD) as part of a project focused on the Early Detection of Lung Diseases (EDLI). The procurement includes specific items such as the Chromium Next GEM Chip K Single Cell Kit and various amplification kits, which are essential for high-resolution gene expression profiling and immune repertoire analysis. This acquisition is critical to ensure the continuity and integrity of ongoing research, as only proprietary reagents from 10X Genomics are compatible with existing NIH equipment. Interested parties capable of providing similar products may submit a capability statement by June 16, 2025, to Tasha Lowe at lowet2@mail.nih.gov.